Mark F. McCarty (2015) “Flavones and Flavonols may have Clinical Potential as CK2 Inhibitors in Cancer Therapy”, Cancer Studies and Molecular Medicine , 2(1), pp. 39–51. doi: 10.17140/CSMMOJ-2-105.